These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15799411)

  • 21. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etanercept and infliximab for rheumatoid arthritis.
    Drug Ther Bull; 2001 Jul; 39(7):49-52. PubMed ID: 11471515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D; La Montagna G
    Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
    [No Abstract]   [Full Text] [Related]  

  • 24. Phlegmonous abscess associated with etanercept therapy.
    D'Amore M; Minenna G; Favoino E; D'Amore S
    Panminerva Med; 2006 Sep; 48(3):199-200. PubMed ID: 17122757
    [No Abstract]   [Full Text] [Related]  

  • 25. Etanercept: anti-tumor necrosis factor therapy for rheumatoid arthritis.
    McGahan L
    Issues Emerg Health Technol; 1999 Oct; (8):1-6. PubMed ID: 11811215
    [No Abstract]   [Full Text] [Related]  

  • 26. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
    Duffy TN; Genta M; Moll S; Martin PY; Gabay C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
    [No Abstract]   [Full Text] [Related]  

  • 27. Can tumor necrosis factor alpha blockade predispose to severe babesiosis?
    Taiwo B; Lee C; Venkat D; Tambar S; Sutton SH
    Arthritis Rheum; 2007 Feb; 57(1):179-81. PubMed ID: 17266091
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
    Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
    Tomono K; Hashimoto S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
    [No Abstract]   [Full Text] [Related]  

  • 30. Etanercept in rheumatoid arthritis.
    Cook DA; Dimick JB; Gallagher DC
    N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383273
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor necrosis factor blockers in rheumatoid arthritis.
    Pisetsky DS
    N Engl J Med; 2000 Mar; 342(11):810-1. PubMed ID: 10717018
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of etanercept plus lamivudine in a patient with rheumatoid arthritis and viral hepatitis B.
    Benucci M; Manfredi M; Mecocci L
    J Clin Rheumatol; 2008 Aug; 14(4):245-6. PubMed ID: 18766129
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
    Mizutani W
    Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Etanercept].
    Kameda H
    Nihon Rinsho; 2013 Jul; 71(7):1214-7. PubMed ID: 23961669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
    Petri A; Dreyer L; Danneskiold-Samsøe B; Terslev L; Bliddal H
    Ugeskr Laeger; 2003 Nov; 165(48):4649-52. PubMed ID: 14677465
    [No Abstract]   [Full Text] [Related]  

  • 36. Etanercept in rheumatoid arthritis.
    Ferraccioli GF; Di Poi E
    N Engl J Med; 1999 Jun; 340(25):2000-1. PubMed ID: 10383275
    [No Abstract]   [Full Text] [Related]  

  • 37. Septic arthritis caused by Rothia dentocariosa in a patient with rheumatoid arthritis receiving etanercept therapy.
    Favero M; Raffeiner B; Cecchin D; Schiavon F
    J Rheumatol; 2009 Dec; 36(12):2846-7. PubMed ID: 19966198
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment.
    Lewicki M; Kotyla P; Kucharz E
    J Rheumatol; 2009 Jun; 36(6):1346-7; author reply 1347. PubMed ID: 19509093
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N; Max R; Schiller M; Briem S; Lorenz HM
    Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
    [No Abstract]   [Full Text] [Related]  

  • 40. Coarctation of the aorta in an infant exposed to etanercept in utero.
    Hemmati I; Stephanie E; Shojania K
    J Rheumatol; 2009 Dec; 36(12):2848. PubMed ID: 19966200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.